These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5027391)

  • 21. [Comparative analysis of influenza virus strains isolated in Poland during the epidemic season 1981-1982].
    Loza-Tulimowska M; Isaczenko WA; Lubowcewa OW; Iwanowa WT; Zakstelskaja LJ; Semkow RA
    Med Dosw Mikrobiol; 1984; 36(1):27-32. PubMed ID: 6738227
    [No Abstract]   [Full Text] [Related]  

  • 22. Recombinant influenza-virus vaccines. IV. Segregation of antigenic and some biological properties of Influenza virus neuraminidase by recombination.
    Higashihara M; Igarashi Y; Saito Y
    Kitasato Arch Exp Med; 1976 Sep; 49(3):81-91. PubMed ID: 1029759
    [No Abstract]   [Full Text] [Related]  

  • 23. Antigenic structure of influenza A viruses; an immunodiffusion study.
    Styk B; Blaskovic D; Hána L; Jakubka J; Sedíleková M
    Acta Virol; 1970 May; 14(3):194-208. PubMed ID: 4392919
    [No Abstract]   [Full Text] [Related]  

  • 24. Antigenic variation in influenza virus. Biology and chemistry.
    Webster RG; Laver WG
    Prog Med Virol; 1971; 13():271-338. PubMed ID: 4950606
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuraminidase and resistance to influenza.
    Lancet; 1972 Aug; 2(7771):264-5. PubMed ID: 4114512
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-neuraminidase activity of anti-influenza serum enhanced by cofactor.
    Polyak RYa ; Smirnova LA
    Acta Virol; 1975 Apr; 19(2):170. PubMed ID: 239568
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody response in man to influenza virus neuraminidase following influenza.
    Kilbourne ED; Christenson WN; Sande M
    J Virol; 1968 Jul; 2(7):761-2. PubMed ID: 5723531
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 29. Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus.
    Webster RG; Laver WG
    J Immunol; 1967 Jul; 99(1):49-55. PubMed ID: 6029282
    [No Abstract]   [Full Text] [Related]  

  • 30. Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.
    Aymard-Henry M; Coleman MT; Dowdle WR; Laver WG; Schild GC; Webster RG
    Bull World Health Organ; 1973; 48(2):199-202. PubMed ID: 4541685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigens (and recombinants) and immune response to avian influenza.
    Easterday BC
    Am J Vet Res; 1975 Apr; 36(4 Pt 2):503-4. PubMed ID: 1092217
    [No Abstract]   [Full Text] [Related]  

  • 32. [Reaction of influenza viruses with thymus-dependent lymphocytes].
    Süss J; Schmidt S; Schmidt J
    Allerg Immunol (Leipz); 1982; 28(3):165-73. PubMed ID: 6183963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential radioassay of influenza-specific 7S (IgG) over 19S (IgM) class of antibodies.
    Daugharty H
    J Immunol; 1973 Aug; 111(2):404-9. PubMed ID: 4577880
    [No Abstract]   [Full Text] [Related]  

  • 34. Antigenic variation in influenza viruses, with special reference to Hong Kong influenza.
    Webster RG
    Bull World Health Organ; 1969; 41(3):483-5. PubMed ID: 5309459
    [No Abstract]   [Full Text] [Related]  

  • 35. [Formation and persistence of antibodies against antigens of influenza virus envelope after natural infection (author's transl)].
    Stumpa A; Kulková H; Tůmová B
    Cesk Epidemiol Mikrobiol Imunol; 1978 Apr; 27(2):69-78. PubMed ID: 149605
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection of influenza virus neuraminidase-specific antibodies by an enzyme-linked immunosorbent assay.
    Khan MW; Gallagher M; Bucher D; Cerini CP; Kilbourne ED
    J Clin Microbiol; 1982 Jul; 16(1):115-22. PubMed ID: 7107850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza.
    Sabin AB
    Dev Biol Stand; 1976; 33():127-40. PubMed ID: 955265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza virus neuraminidase: structure, antibodies, and inhibitors.
    Colman PM
    Protein Sci; 1994 Oct; 3(10):1687-96. PubMed ID: 7849585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influenza virus, human: two avenues for the new treatment].
    Casselyn M
    Rev Med Suisse; 2009 Mar; 5(194):605. PubMed ID: 19405281
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody response to influenza vaccine in coronary artery disease: a substudy of the FLUCAD study.
    Brydak LB; Romanowska M; Nowak I; Ciszewski A; Bilińska ZT
    Med Sci Monit; 2009 Jul; 15(7):PH85-91. PubMed ID: 19564837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.